ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Impact of melanoma histological regression on first-line immunotherapy response in stage-IV disease.
Jean-Baptiste Such et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.